- Filed
- Mar 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 27, 2025 | 11.7M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 6.5M sh |
| Capex | FY 2024 · Dec 31, 2023 | $214K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$51.61M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $23.96M |
| Current Liabilities restated | FY 2024 · Dec 31, 2023 | $30.29M |
| Current Assets | FY 2024 · Dec 31, 2023 | $49.91M |
| Total Assets | FY 2024 · Dec 31, 2023 | $75.55M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$9.42 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$9.42 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $14.56M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $43.97M |
| Net Income restated | FY 2024 · Dec 31, 2023 | −$61.27M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$55.16M |
| Revenue | FY 2024 · Dec 31, 2023 | $3.37M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $82.61M |